In a study of melanoma and NSCLC, 3 patients encountered pseudoprogression during treatment, with imaging findings showing tumor enlargement and a significant decrease in serum IL-8 levels, and serum IL-8 levels remained below baseline when tumor load back to normal. This evidence concerns the gene CXCL8 and melanoma.